JPWO2022102687A1 - - Google Patents
Info
- Publication number
- JPWO2022102687A1 JPWO2022102687A1 JP2022561980A JP2022561980A JPWO2022102687A1 JP WO2022102687 A1 JPWO2022102687 A1 JP WO2022102687A1 JP 2022561980 A JP2022561980 A JP 2022561980A JP 2022561980 A JP2022561980 A JP 2022561980A JP WO2022102687 A1 JPWO2022102687 A1 JP WO2022102687A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020187983 | 2020-11-11 | ||
PCT/JP2021/041444 WO2022102687A1 (ja) | 2020-11-11 | 2021-11-11 | がん治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPWO2022102687A1 true JPWO2022102687A1 (ko) | 2022-05-19 |
Family
ID=81601291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022561980A Pending JPWO2022102687A1 (ko) | 2020-11-11 | 2021-11-11 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2022102687A1 (ko) |
WO (1) | WO2022102687A1 (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3083343C (en) * | 2017-12-28 | 2022-04-26 | J-Pharma Co., Ltd. | O-(5-amino-2-phenylbenzoxazol-7-yl)methyl-3,5-dichloro-l-tyrosine for use in treating cancer |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170001962A (ko) * | 2014-05-15 | 2017-01-06 | 제이 파마 가부시끼가이샤 | 항 악성 종양제 조성물 |
US11899019B2 (en) * | 2017-11-07 | 2024-02-13 | J-Pharma Co., Ltd. | Method for predicting efficacy of anti-PD-1 antibody or anti-PD-L1 antibody therapy, method for evaluating cancer grade, and method for enhancing efficacy of anti-PD-1 antibody or anti-PD-L1 antibody therapy |
CA3083343C (en) * | 2017-12-28 | 2022-04-26 | J-Pharma Co., Ltd. | O-(5-amino-2-phenylbenzoxazol-7-yl)methyl-3,5-dichloro-l-tyrosine for use in treating cancer |
-
2021
- 2021-11-11 WO PCT/JP2021/041444 patent/WO2022102687A1/ja active Application Filing
- 2021-11-11 JP JP2022561980A patent/JPWO2022102687A1/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2022102687A1 (ja) | 2022-05-19 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230515 |